Response to Drug-Eluting Stents. Do We Need Drugs to Recompense Drug Elution?

Journal of the American College of Cardiology

Volumn 54, Issue 24, 2009, Pages 2330-2332

  Nickenig, Georg ^a   Sinning, Jan Malte ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

inflammation; smooth muscle; stents; vasoconstriction

Indexed keywords

RHO KINASE;

BARE METAL STENT; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; DRUG ELUTING STENT; EDITORIAL; IMMUNOHISTOCHEMISTRY; IMPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

ANIMALS; CONSTRICTION, PATHOLOGIC; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; PACLITAXEL; RHO-ASSOCIATED KINASES; SWINE;

EID: 70549111033     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.07.048     Document Type: Editorial

References (18)

1. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
2. Luscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
3. Wilson G.J., Nakazawa G., Schwartz R.S., et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 120 (2009) 141-149
4. Togni M., Windecker S., Cocchia R., et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46 (2005) 231-236
5. Hofma S.H., van der Giessen W.J., van Dalen B.M., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
6. Shiroto T., Yasuda S., Tsuburaya R., et al. Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stent in pigs in vivo. J Am Coll Cardiol 54 (2009) 2321-2329
7. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
8. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 64 (2000) 1-12
9. Maseri A., Davies G., Hackett D., and Kaski J.C. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 81 (1990) 1983-1991
10. Obata J.E., Kitta Y., Takano H., et al. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 50 (2007) 1305-1309
11. Takemoto M., Sun J., Hiroki J., Shimokawa H., and Liao J.K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106 (2002) 57-62
12. Matsumoto Y., Uwatoku T., Oi K., et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 24 (2004) 181-186
13. Ferrero V., Ribichini F., Rognoni A., Marino P., Brunelleschi S., and Vassanelli C. Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study). Am J Cardiol 99 (2007) 1082-1086
14. Sueda S., Kohno H., Fukuda H., et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 15 (2004) 491-497
15. Shimokawa H., Tomoike H., Nabeyama S., et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 221 (1983) 560-562
16. Nohria A., Grunert M.E., Rikitake Y., et al. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 99 (2006) 1426-1432
17. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
18. Laufs U., Endres M., Custodis F., et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102 (2000) 3104-3110